Does ENZALUTAMIDE Cause Product size issue? 539 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 539 reports of Product size issue have been filed in association with ENZALUTAMIDE (Xtandi). This represents 1.1% of all adverse event reports for ENZALUTAMIDE.
539
Reports of Product size issue with ENZALUTAMIDE
1.1%
of all ENZALUTAMIDE reports
65
Deaths
68
Hospitalizations
How Dangerous Is Product size issue From ENZALUTAMIDE?
Of the 539 reports, 65 (12.1%) resulted in death, 68 (12.6%) required hospitalization, and 6 (1.1%) were considered life-threatening.
Is Product size issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 539 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Product size issue?
DIMETHICONE\LOPERAMIDE (416)
ACETAMINOPHEN (150)
NIRMATRELVIR\RITONAVIR (140)
ESTRADIOL (120)
ABIRATERONE (115)
GUAIFENESIN (111)
IBUPROFEN (102)
DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN (101)
RIVAROXABAN (92)
LOPERAMIDE (88)
Which ENZALUTAMIDE Alternatives Have Lower Product size issue Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE